Key terms
About AGE
AgeX Therapeutics, Inc. operates as a biotechnology company, which engages in the development and commercialization of novel therapeutics targeting human aging and degenerative diseases. Its product pipeline includes AGEX-VASC1, AGEX-BAT1, and AGEX-iTR1547. The company was founded by Michael D. West in 2017 and is headquartered in Alameda, CA.
Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
52-week range
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date
Key terms
Ad Feedback
Smart score
Latest AGE news
Mar 18
11:03am ET
Biotech Alert: Searches spiking for these stocks today
Mar 15
10:22am ET
AgeX Therapeutics Inc trading resumes
Mar 15
10:12am ET
AgeX Therapeutics Inc trading halted, volatility trading pause
Feb 14
4:38pm ET
AgeX Therapeutics Secures Funding, Details in SEC Report
Feb 07
4:45am ET
AgeX Therapeutics Postpones Merger Completion with Serina
Feb 07
4:44am ET
AgeX Therapeutics Expands Ties with JuvVentures Equity Deal
Feb 07
4:44am ET
AgeX Therapeutics Secures $500K Convertible Note Deal
No recent news articles are available for AGE
No recent press releases are available for AGE
AGE Financials
Key terms
Ad Feedback
AGE Forecasts
analyst rating
- buy
- hold
- sell
1-year stock price forecast
AGE Competitors
$ Market cap
P/E ratio
$ Price
1d change
52-week range